PriceTargets.com logo

NYSE:ACB - Aurora Cannabis Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $6.78
  • Forecasted Upside: 6.10 %
  • Number of Analysts: 11
  • Breakdown:
  • 7 Sell Ratings
  • 4 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$6.39 As of 09/27/2021 05:00 PM ET
▲ +0.44 (7.39%)

This chart shows the closing price for ACB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aurora Cannabis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ACB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ACB

Analyst Price Target is $6.78
▲ +6.10% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Aurora Cannabis in the last 3 months. The average price target is $6.78, with a high forecast of $8.30 and a low forecast of $3.60. The average price target represents a 6.10% upside from the last price of $6.39.

This chart shows the closing price for ACB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Sell

The current consensus among 11 investment analysts is to sell stock in Aurora Cannabis. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 9 hold ratings
  • 8 sell ratings
Ratings as of
4/5/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 9 hold ratings
  • 8 sell ratings
Ratings as of
7/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 9 hold ratings
  • 8 sell ratings
Ratings as of
10/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 10 hold ratings
  • 9 sell ratings
Ratings as of
12/31/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 8 hold ratings
  • 7 sell ratings
Ratings as of
3/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 7 sell ratings
Ratings as of
6/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 7 sell ratings
Ratings as of
8/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 7 sell ratings
Ratings as of
9/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 7 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/23/2021CIBCLower Price TargetUnderperformC$8.00 ➝ C$7.00Low
9/17/2021Cantor FitzgeraldLower Price TargetNeutralC$12.00 ➝ C$8.30Low
9/3/2021Jefferies Financial GroupUpgradeUnderperform ➝ Hold$7.49 ➝ $6.78Medium
7/23/2021Atb Cap MarketsReiterated RatingUnderperformHigh
5/20/2021Canaccord GenuityReiterated RatingHold ➝ Sell$14.00 ➝ $7.00Low
5/17/2021CIBCLower Price TargetNeutral ➝ UnderperformerC$15.00 ➝ C$9.00N/A
5/14/2021Needham & Company LLCInitiated CoverageSellLow
5/14/2021Cantor FitzgeraldLower Price TargetNeutral$11.25 ➝ $9.00High
5/14/2021Canaccord GenuityDowngradeHold ➝ Sell$14.00 ➝ $7.00High
5/14/2021BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$9.00 ➝ $8.00High
5/11/2021CIBCDowngradeNeutral ➝ Sector Underperform$15.00 ➝ $9.00Low
4/28/2021Bank of AmericaInitiated CoverageNeutralHigh
4/5/2021CIBCLower Price TargetNeutral$18.50 ➝ $15.00Low
2/16/2021CIBCBoost Price TargetNeutral$17.00 ➝ $18.50Low
2/12/2021Canaccord GenuityBoost Price TargetNeutral ➝ Hold$11.00 ➝ $14.00Low
2/12/2021MKM PartnersDowngradeNeutral ➝ SellLow
2/12/2021Needham & Company LLCDowngradeHold ➝ UnderperformLow
2/12/2021Cantor FitzgeraldBoost Price TargetNeutral$17.00 ➝ $18.00Low
2/12/2021DesjardinsDowngradeHold ➝ SellLow
2/8/2021CIBCBoost Price TargetNeutral$15.00 ➝ $17.00High
2/5/2021Cantor FitzgeraldBoost Price TargetNeutral$16.00 ➝ $17.00Low
1/25/2021Cantor FitzgeraldBoost Price TargetNeutral$12.00 ➝ $16.00Medium
1/4/2021Jefferies Financial GroupReiterated RatingUnderperform$4.59N/A
12/17/2020BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$9.00Low
11/16/2020Atb Cap MarketsUpgradeUnderperform ➝ Sector PerformLow
11/16/2020Jefferies Financial GroupDowngradeHold ➝ Underperform$5.56 ➝ $3.75Low
11/11/2020Stifel NicolausDowngradeHold ➝ SellN/A
11/10/2020CIBCBoost Price TargetNeutral$12.00 ➝ $15.00Low
11/10/2020Canaccord GenuityBoost Price TargetHold$8.50 ➝ $11.00Low
11/9/2020Atb Cap MarketsDowngradeSector Perform ➝ UnderperformMedium
11/9/2020Cantor FitzgeraldDowngradeOverweight ➝ Neutral$13.00 ➝ $12.00High
10/28/2020Stifel NicolausLower Price TargetHold$10.50 ➝ $3.60Medium
10/27/2020Cantor FitzgeraldDowngradeOverweight ➝ Neutral$18.00 ➝ $7.00High
9/24/2020CIBCLower Price TargetNeutral$20.00 ➝ $12.00Low
9/23/2020CowenReiterated RatingHold$10.00Low
9/23/2020Cantor FitzgeraldBoost Price TargetOverweight$17.50 ➝ $18.00High
9/23/2020Needham & Company LLCReiterated RatingHoldHigh
9/23/2020Piper SandlerLower Price TargetNeutral$10.00 ➝ $8.00High
9/22/2020Canaccord GenuityLower Price TargetHold$21.00 ➝ $10.00High
9/21/2020Jefferies Financial GroupUpgradeUnderperform ➝ HoldHigh
9/9/2020Stifel NicolausLower Price TargetPositive ➝ Hold$16.00 ➝ $10.50High
9/9/2020Cantor FitzgeraldLower Price TargetOverweight$29.00 ➝ $17.50Low
9/8/2020Needham & Company LLCReiterated RatingHoldHigh
9/8/2020LADENBURG THALM/SH SHDowngradeBuy ➝ Neutral$9.00High
8/18/2020CIBCLower Price TargetNeutral$24.00 ➝ $20.00Low
6/24/2020Cantor FitzgeraldBoost Price TargetOverweight$27.00 ➝ $29.00Medium
6/24/2020Stifel NicolausUpgradeSell ➝ Hold$6.20 ➝ $17.50Low
6/23/2020Needham & Company LLCInitiated CoverageHoldLow
5/22/2020CIBCBoost Price TargetNeutral$14.00 ➝ $24.00Low
5/22/2020Jefferies Financial GroupDowngradeHold ➝ Underperform$12.00 ➝ $14.00Medium
5/21/2020Cantor FitzgeraldBoost Price TargetMarket Perform ➝ Overweight$22.00 ➝ $27.00High
5/19/2020MKM PartnersInitiated CoverageHold$18.00High
5/18/2020CIBCReiterated RatingBuy ➝ Market Perform$27.00 ➝ $14.00High
5/15/2020Pi FinancialReiterated RatingNeutralHigh
5/15/2020DesjardinsUpgradeBuyHigh
5/15/2020Piper SandlerUpgradeUnderweight ➝ Neutral$12.00 ➝ $10.00High
5/13/2020Cantor FitzgeraldBoost Price TargetOverweight$22.00High
5/12/2020Eight CapitalReiterated RatingHold$11.00High
4/13/2020Cantor FitzgeraldLower Price TargetOverweight$45.60 ➝ $33.00Low
4/13/2020Needham & Company LLCReiterated RatingHoldHigh
2/27/2020Bryan, Garnier & CoDowngradeNeutral ➝ SellLow
2/25/2020Needham & Company LLCInitiated CoverageHold$18.00High
2/24/2020Cantor FitzgeraldBoost Price TargetOverweight$45.00 ➝ $45.60Low
2/24/2020CowenDowngradeOutperform ➝ Market Perform$72.00 ➝ $30.00Medium
2/16/2020Pi FinancialReiterated RatingHold$24.00High
2/16/2020CIBCReiterated RatingHold$27.00High
2/14/2020MKM PartnersUpgradeSell ➝ NeutralLow
2/14/2020Canaccord GenuityReiterated RatingHold$27.00Low
2/10/2020CIBCReiterated RatingHold$30.00High
2/7/2020Pi FinancialDowngradeHold$24.00High
2/7/2020Eight CapitalDowngradeBuy ➝ NeutralLow
2/7/2020Cantor FitzgeraldLower Price TargetOverweight$60.00 ➝ $45.00Low
2/7/2020Compass PointLower Price TargetNeutral$60.00 ➝ $24.00High
2/7/2020Canaccord GenuityDowngradeBuy ➝ HoldLow
2/6/2020Jefferies Financial GroupDowngradeHoldHigh
1/10/2020Piper Jaffray CompaniesDowngradeNeutral ➝ Underweight$36.00 ➝ $12.00Low
1/10/2020Bank of AmericaDowngradeNeutral ➝ Underperform$12.00High
1/10/2020Piper SandlerDowngradeOverweight ➝ Neutral$36.00 ➝ $12.00High
12/31/2019Jefferies Financial GroupDowngradeHold$36.00High
12/23/2019MKM PartnersReiterated RatingSell$36.00 ➝ $24.00Medium
12/23/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$36.00Medium
11/26/2019Cantor FitzgeraldReiterated RatingBuy$52.80Low
11/15/2019MKM PartnersDowngradeHold$42.00 ➝ $36.00High
11/15/2019Cantor FitzgeraldUpgradeNeutral ➝ Overweight$61.20 ➝ $70.20High
11/15/2019Piper Jaffray CompaniesLower Price TargetNeutral$48.00 ➝ $36.00High
11/4/2019Cantor FitzgeraldInitiated CoverageNeutral$61.20High
10/22/2019Piper Jaffray CompaniesLower Price TargetNeutral$84.00 ➝ $48.00Medium
10/15/2019Pi FinancialSet Price TargetBuy$84.00High
10/11/2019Jefferies Financial GroupSet Price TargetBuy$84.00Low
9/24/2019CIBCInitiated CoverageNeutral$84.00High
9/20/2019MKM PartnersDowngradeSellLow
9/19/2019MKM PartnersInitiated CoverageBuy$60.00Medium
9/13/2019Canaccord GenuitySet Price TargetBuy$162.00Medium
9/13/2019Piper Jaffray CompaniesSet Price TargetHold$84.00High
9/12/2019Compass PointSet Price TargetHold$96.00High
9/12/2019Stifel NicolausReiterated RatingHold ➝ Sell$84.00 ➝ $60.00High
8/12/2019Piper Jaffray CompaniesInitiated CoverageNeutral ➝ Neutral$84.00Low
7/18/2019Bank of AmericaDowngradeBuy ➝ Neutral$87.60High
7/17/2019LADENBURG THALM/SH SHInitiated CoverageBuy ➝ Buy$108.00Medium
7/8/2019Compass PointInitiated CoverageNeutral ➝ NeutralMedium
6/5/2019Stifel NicolausInitiated CoverageHold ➝ HoldMedium
4/25/2019DesjardinsInitiated CoverageBuy ➝ Buy$108.84Low
4/17/2019Bank of AmericaInitiated CoverageBuy ➝ Buy$132.00Medium
3/13/2019GMP SecuritiesUpgradeHold ➝ BuyHigh
3/5/2019CowenInitiated CoverageOutperformHigh
2/25/2019Jefferies Financial GroupInitiated CoverageBuy ➝ BuyHigh
2/21/2019Seaport Global SecuritiesInitiated CoverageNeutral ➝ NeutralLow
2/12/2019GMP SecuritiesReiterated RatingHold$114.00High
11/10/2017Canaccord GenuityReiterated RatingBuy$53.40N/A
(Data available from 9/27/2016 forward)

News Sentiment Rating

0.28 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
3/1/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/31/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/30/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/30/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/29/2021
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/29/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2021
  • 5 very positive mentions
  • 16 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2021

Current Sentiment

  • 5 very positive mentions
  • 16 positive mentions
  • 4 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Aurora Cannabis logo
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Calgary, Canada.
Read More

Today's Range

Now: $6.39
Low: $5.89
High: $6.50

50 Day Range

MA: $6.92
Low: $5.95
High: $7.52

52 Week Range

Now: $6.39
Low: $3.71
High: $18.98

Volume

11,438,325 shs

Average Volume

11,549,426 shs

Market Capitalization

$1.27 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.17

Frequently Asked Questions

What sell-side analysts currently cover shares of Aurora Cannabis?

The following Wall Street analysts have issued research reports on Aurora Cannabis in the last twelve months: Atb Cap Markets, Bank of America Co., BMO Capital Markets, Canaccord Genuity, Cantor Fitzgerald, CIBC, Desjardins, Jefferies Financial Group Inc., MKM Partners, Needham & Company LLC, Stifel Nicolaus, and Zacks Investment Research.
View the latest analyst ratings for ACB.

What is the current price target for Aurora Cannabis?

6 Wall Street analysts have set twelve-month price targets for Aurora Cannabis in the last year. Their average twelve-month price target is $6.78, suggesting a possible upside of 4.5%. Cantor Fitzgerald has the highest price target set, predicting ACB will reach $8.30 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $3.60 for Aurora Cannabis in the next year.
View the latest price targets for ACB.

What is the current consensus analyst rating for Aurora Cannabis?

Aurora Cannabis currently has 7 sell ratings and 4 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe ACB will underperform the market and that investors should sell shares of Aurora Cannabis.
View the latest ratings for ACB.

What other companies compete with Aurora Cannabis?

Other companies that are similar to Aurora Cannabis include Cronos Group, USANA Health Sciences, Sundial Growers, True Drinks, Canopy Rivers, ChromaDex, HEXO, MediWound, Natural Alternatives International, Grove, FitLife Brands, Bon Natural Life, Mannatech, Charlie's and Glucose Health.

How do I contact Aurora Cannabis' investor relations team?

Aurora Cannabis' physical mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company's listed phone number is (855) 279-4652 and its investor relations email address is [email protected] The official website for Aurora Cannabis is auroramj.com.